Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources
 April 10th, 2025


Compound category: Organic compounds
(total 903 related compounds in database, current show from 851 to 860)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
2,6-bis[4-(4-aminophenyl)sulfonylphenyl]pyrrolo[3,4-f]isoindole-1,3,5,7-tetrone Depiction based on curated SMILES N S O O O NH 2 O N S O O NH 2 O O Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
2,8-bis(5-methyl-2-furyl)pyrido[3,2-g]quinoline-4,6-dicarboxylic acid Depiction based on curated SMILES O OH O O H 3 C N N CH 3 OH O Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
2-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)iminoindene-1,3-dione Depiction based on curated SMILES H 3 C N N O O H 3 C O N Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-5-chloro-N-(3,4-dichlorophenyl)benzamide Depiction based on curated SMILES Cl Cl N H O Cl N H O O S N S N Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Kauppi AM, et al. 2003. Chem Biol
2-chloro-4-{5-[(E)-2-(4,6-dihydroxy-5-nitropyrimidin-2-yl)ethenyl]furan-2-yl}benzoic acid Depiction based on curated SMILES O NH O _ O O + N HO N O Cl OH Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
2-chloro-5-[5-[(Z)-[1-(furan-2-ylmethyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene]methyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O O N S N H O O Cl OH Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
2-hydroxy-5-[5-[(E)-3-oxo-3-[4-(3-phenyl-1,2,4-thiadiazol-5-yl)-1,4-diazepan-1-yl]prop-1-enyl]furan-2-yl]benzoic acid Depiction based on curated SMILES OH O HO N N S N N O O Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
2-hydroxy-5-[5-[(E)-3-oxo-3-[[3-oxo-3-[(3-phenyl-1,2,4-thiadiazol-5-yl)amino]propyl]amino]prop-1-enyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O OH O HO N S N N H O N H Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
2-hydroxy-5-[5-[(E)-3-[[3-[[3-(4-hydroxyphenyl)-1,2,4-thiadiazol-5-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O OH O OH HO N S N N H O N H Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
2-hydroxy-5-{5-[(E)-{2-[(5-phenyl-2H-tetrazol-2-yl)acetyl]hydrazinylidene}methyl]furan-2-yl}benzoic acid Depiction based on curated SMILES OH O HO O N N H O N N N N Yersinia TTSS secreted effectors Preclinical (in vitro) Tautz L, et al. 2005. J Biol Chem
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91 



Back to top
2004-2025 NIPB, CAMS&PUMC